<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33905071</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7365</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Metabolic brain disease</Title><ISOAbbreviation>Metab Brain Dis</ISOAbbreviation></Journal><ArticleTitle>RNA as a source of biomarkers for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1697</StartPage><EndPage>1702</EndPage><MedlinePgn>1697-1702</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11011-021-00738-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, leads to the loss of motor neurons. There are currently no effective therapies to treat this disease as the molecular mechanisms of motor neuron degeneration are largely unknown. The diagnosis of ALS, or motor neuron disease, is not a simple process that can be carried out with one doctor visit or a single simple test. This has created a major problem for patients with ALS and their physicians since they are often not diagnosed until about a year into the disease. In order to combat this issue, new techniques of detecting the clinical and pathological changes of the disease are critical. These techniques are currently being studied and developed which can revolutionize the diagnosis of ALS. Once this technology is established, it may have application to monitor the progression of the disease. RNA-Seq is a powerful tool that has potential to identify RNA as small molecules in patients' biological samples (Plasma, Cerebral Spinal Fluid) which can be used to inform the system changes in patients with ALS. In this review, we will explore and discuss our current work on RNA-Seq and its development of biomarkers to diagnose and assess the rate of progression in the disease.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiaei</LastName><ForeName>Lily</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>RockGen Therapeutics, LLC, Little Rock, AR, 72205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiaei</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0802-1426</Identifier><AffiliationInfo><Affiliation>RockGen Therapeutics, LLC, Little Rock, AR, 72205, USA. kiaeim@rockgenbio.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, AR, Little Rock, USA. kiaeim@rockgenbio.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, University of Arkansas for Medical Sciences, AR, Little Rock, USA. kiaeim@rockgenbio.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. kiaeim@rockgenbio.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Metab Brain Dis</MedlineTA><NlmUniqueID>8610370</NlmUniqueID><ISSNLinking>0885-7490</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Metab Brain Dis. 2022 Mar;37(3):849</RefSource><PMID Version="1">35098415</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Degeneration</Keyword><Keyword MajorTopicYN="N">Diagnostic markers</Keyword><Keyword MajorTopicYN="N">Motor neurons</Keyword><Keyword MajorTopicYN="N">RNAs</Keyword><Keyword MajorTopicYN="N">mRNA</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33905071</ArticleId><ArticleId IdType="doi">10.1007/s11011-021-00738-z</ArticleId><ArticleId IdType="pii">10.1007/s11011-021-00738-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A et al (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 8:157&#x2013;164</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.2.157</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkam D, Feldman EZ, Singh A, Kiaei M (2017) Profilin1 biology and its mutation, actin(g) in disease Cell. Mol Life Sci 74:967&#x2013;981. https://doi.org/10.1007/s00018-016-2372-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2372-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Audoy-Remus J et al (2015) GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer&#x2019;s disease. Brain Behav Immun 46:112&#x2013;120. https://doi.org/10.1016/j.bbi.2015.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.01.010</ArticleId><ArticleId IdType="pubmed">25637481</ArticleId></ArticleIdList></Reference><Reference><Citation>Barham C, Fil D, Byrum SD, Rahmatallah Y, Glazko G, Kiaei M (2018) RNA-Seq analysis of spinal cord tissues from hPFN1(G118V) transgenic mouse model of ALS at pre-symptomatic and end-stages of disease. Sci Rep 8:13737. https://doi.org/10.1038/s41598-018-31132-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31132-y</ArticleId><ArticleId IdType="pubmed">30213953</ArticleId><ArticleId IdType="pmc">6137178</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M et al (2020) Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95:e59&#x2013;e69. https://doi.org/10.1212/WNL.0000000000009559</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009559</ArticleId><ArticleId IdType="pubmed">32385188</ArticleId><ArticleId IdType="pmc">7371380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X et al (2014) Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity. Protein Cell 5:912&#x2013;927. https://doi.org/10.1007/s13238-014-0104-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0104-6</ArticleId><ArticleId IdType="pubmed">25311841</ArticleId><ArticleId IdType="pmc">4259884</ArticleId></ArticleIdList></Reference><Reference><Citation>Coluccio LM, Tilney LG (1983) Under physiological conditions actin disassembles slowly from the nonpreferred end of an actin filament. J Cell Biol 97:1629&#x2013;1634. https://doi.org/10.1083/jcb.97.5.1629</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.97.5.1629</ArticleId><ArticleId IdType="pubmed">6630295</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Dobrzeniecka S, Camu W, Meininger V, Dupre N, Dion PA, Rouleau GA (2013) Mutation analysis of PFN1 in familial amyotrophic lateral sclerosis patients. Neurobiol Aging 34(4):1311.e1&#x2013;1311.e2. https://doi.org/10.1016/j.neurobiolaging.2012.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLoach A, Cozart M, Kiaei A, Kiaei M (2015) A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies. Expert Opin Drug Discov: 1&#x2013;20. https://doi.org/10.1517/17460441.2015.1067197</Citation></Reference><Reference><Citation>Echelard S, Hoyaux D, Hermans M, Daelemans P, Roth J, Philippart P, Pochet R (2002) S100A8 and S100A9 calcium-binding proteins: localization within normal and cyclosporin A-induced overgrowth gingiva. Connect Tissue Res 43:419&#x2013;424. https://doi.org/10.1080/03008200290001230</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03008200290001230</ArticleId><ArticleId IdType="pubmed">12489193</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D et al (2017) Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum Mol Genet 26:686&#x2013;701. https://doi.org/10.1093/hmg/ddw429</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw429</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F et al (2004) A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem 279:45951&#x2013;45956</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408139200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME et al (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772&#x2013;1775. https://doi.org/10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatem S, Hoyaux D, De Decker V, Appelboom T, Pochet R, Steinfeld S (2002) Expression of calcium-sensing receptor in human minor salivary glands. Clin Exp Rheumatol 20:576</Citation><ArticleIdList><ArticleId IdType="pubmed">12175122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyaux D et al (2002) S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. J Neuropathol Exp Neurol 61:736&#x2013;744. https://doi.org/10.1093/jnen/61.8.736</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.8.736</ArticleId><ArticleId IdType="pubmed">12152788</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F et al (2020) Longitudinal biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 7:1103&#x2013;1116. https://doi.org/10.1002/acn3.51078</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51078</ArticleId><ArticleId IdType="pubmed">32515902</ArticleId><ArticleId IdType="pmc">7359115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C et al (2013) A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging 34:1708 e1701&#x2013;e1706</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.10.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G et al (2020) Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis. Brain Commun 2:fcaa053. https://doi.org/10.1093/braincomms/fcaa053</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa053</ArticleId><ArticleId IdType="pubmed">32613197</ArticleId><ArticleId IdType="pmc">7329382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkert WJ et al (2015) Predictors and prognostic consequence of gastrointestinal bleeding in patients with ST-segment elevation myocardial infarction. Int J Cardiol 184:128&#x2013;134. https://doi.org/10.1016/j.ijcard.2015.01.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.01.041</ArticleId><ArticleId IdType="pubmed">25703420</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ (2012) The autophagy community. Autophagy 8:1003. https://doi.org/10.4161/auto.20666</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.20666</ArticleId><ArticleId IdType="pubmed">22647354</ArticleId><ArticleId IdType="pmc">3429537</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Saltiel AR (2012) Autophagy works out. Cell Metab 15:273&#x2013;274. https://doi.org/10.1016/j.cmet.2012.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.02.008</ArticleId><ArticleId IdType="pubmed">22405064</ArticleId><ArticleId IdType="pmc">3308187</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Le Ber I, Camuzat A, Brice A, Kabashi E (2013) Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France. Neurobiol Aging 34:1709 e1701-e1702. https://doi.org/10.1016/j.neurobiolaging.2012.10.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.10.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelsen-Preusse K, Zessin S, Grigoryan G, Scharkowski F, Feuge J, Remus A, Korte M (2016) Neuronal profilins in health and disease: Relevance for spine plasticity and Fragile X syndrome. Proc Natl Acad Sci U S A 113:3365&#x2013;3370. https://doi.org/10.1073/pnas.1516697113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1516697113</ArticleId><ArticleId IdType="pubmed">26951674</ArticleId><ArticleId IdType="pmc">4812738</ArticleId></ArticleIdList></Reference><Reference><Citation>Mockrin SC, Korn ED (1980) Acanthamoeba profilin interacts with G-actin to increase the rate of exchange of actin-bound adenosine 5&#x2019;-triphosphate. Biochemistry 19:5359&#x2013;5362. https://doi.org/10.1021/bi00564a033</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00564a033</ArticleId><ArticleId IdType="pubmed">6893804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy N et al (2002) The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin. Histol Histopathol 17:123&#x2013;130. https://doi.org/10.14670/HH-17.123</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/HH-17.123</ArticleId><ArticleId IdType="pubmed">11813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci 9:68. https://doi.org/10.3389/fnagi.2017.00068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId><ArticleId IdType="pmc">5360725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59&#x2013;62. https://doi.org/10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN et al (2014) Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84:324&#x2013;331. https://doi.org/10.1016/j.neuron.2014.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId><ArticleId IdType="pmc">4521390</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN et al (2015) Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiol Aging 36(1602):e1617-1627. https://doi.org/10.1016/j.neurobiolaging.2014.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197&#x2013;206. https://doi.org/10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId><ArticleId IdType="pmc">5585017</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilney LG, Bonder EM, Coluccio LM, Mooseker MS (1983) Actin from Thyone sperm assembles on only one end of an actin filament: a behavior regulated by profilin. J Cell Biol 97:112&#x2013;124. https://doi.org/10.1083/jcb.97.1.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.97.1.112</ArticleId><ArticleId IdType="pubmed">6863386</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiloca C et al (2013) Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiol Aging 34:1517 e1519&#x2013;e1510</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57&#x2013;63. https://doi.org/10.1038/nrg2484</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2484</ArticleId><ArticleId IdType="pubmed">19015660</ArticleId><ArticleId IdType="pmc">2949280</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ (2001) Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci U S A 98:3832&#x2013;3836. https://doi.org/10.1073/pnas.051515498</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051515498</ArticleId><ArticleId IdType="pubmed">11274401</ArticleId><ArticleId IdType="pmc">31138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CH et al (2012) Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488:499&#x2013;503</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S (2014) Assessment of the impact of using a reference transcriptome in mapping short RNA-Seq reads. PLoS One 9:e101374. https://doi.org/10.1371/journal.pone.0101374</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0101374</ArticleId><ArticleId IdType="pubmed">24992027</ArticleId><ArticleId IdType="pmc">4081564</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>